A functional CD40 receptor is expressed in pancreatic beta cells

Overview of attention for article published in Diabetologia, February 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

patent: 7 patents

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

ANTI-CD40 ANTIBODIES FOR USE IN TREATMENT OF T1DM AND INSULITIS

Application WO-2020225736-A1

World Intellectual Property Organisation (WIPO)

12 Nov 2020

Methods of treating CD166-expressing cancer

Grant US-10765742-B2

United States of America

08 Sep 2020

Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand

Grant US-10670603-B2

United States of America

02 Jun 2020

ILT3 polypeptides and uses thereof

Grant US-9822161-B2

United States of America

21 Nov 2017

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.